Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4Warts 1Neoplasm Metastasis 1Metabolic Syndrome 1Heart Failure 1Cardiovascular Diseases 1

Interventions

Metformin 7Magnetic Resonance Spectroscopy 2Inositol 2Exercise 2Ethinyl Estradiol 2maltodextrin 1drospirenone and ethinyl estradiol combination 1drospirenone 1Walking 1Triptorelin Pamoate 1Testosterone 1Sugars 1Spironolactone 1Pyruvic Acid 1Preoperative Exercise 1Pioglitazone 1Phlebotomy 1Pancreaticoduodenectomy 1Orchiectomy 1Leuprolide 1Hepatectomy 1Flutamide 1Etanercept 1Estrogens 1Diet, Reducing 1Diet, Mediterranean 1Diet, Fat-Restricted 1Diet Therapy 1Diet 1Diathermy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Metabolic Syndrome × Pyruvic Acid × Clear all
NCT06645691 2024-12-06

POLARIC-13

National Heart Centre Singapore

Phase 2 Recruiting
200 enrolled

Cardiovascular Diseases, Heart Failure, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡